IRISH Life & Permanent has restated its 2004 results to adjust them for new international financial reporting standards (IFRS) now in effect.

SHARES in Irish drug company Elan were hammered again in Dublin yesterday as news of a second death linked to its multiple sclerosis drug, Tysabri, hit the market.